Re: Enzalutamide Monotherapy vs. Active Surveillance in Patients With Low-risk or Intermediate-risk Localized Prostate Cancer: The ENACT Randomized Clinical Trial

被引：0
|
作者：
Taneja, Samir S.
机构：
来源：
JOURNAL OF UROLOGY | 2023年 / 209卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：636 / 637
页数：2
相关论文
共 50 条
  • [1] Re: Active Surveillance Plus Enzalutamide Monotherapy vs Active Surveillance Alone in Patients with Low-risk or Intermediate-risk Localized Prostate Cancer: The ENACT Randomized Clinical Trial
    Kesch, Claudia
    Hadaschik, Boris A.
    [J]. EUROPEAN UROLOGY, 2022, 82 (05) : 572 - 572
  • [2] Active Surveillance Plus Enzalutamide Monotherapy vs Active Surveillance Alone in Patients With Low-risk or Intermediate-risk Localized Prostate Cancer The ENACT Randomized Clinical Trial
    Shore, Neal D.
    Renzulli, Joseph
    Fleshner, Neil E.
    Hollowell, Courtney M. P.
    Vourganti, Srinivas
    Silberstein, Jonathan
    Siddiqui, Rizwan
    Hairston, John
    Elsouda, Dina
    Russell, David
    Cooperberg, Matthew R.
    Tomlins, Scott A.
    [J]. JAMA ONCOLOGY, 2022, 8 (08) : 1128 - 1136
  • [3] Enzalutamide Monotherapy vs Active Surveillance in Patients With Low-Risk or Intermediate-Risk Localized Prostate Cancer: The ENACT Randomized Clinical Trial (Jun, 10.1001/jamadermatol.2022.1641, 2022)
    Shore, N. D.
    Renzulli, J.
    Fleshner, N. E.
    [J]. JAMA ONCOLOGY, 2022, 8 (08) : 1225 - 1225
  • [4] Re: Neal D. Shore, Joseph Renzulli, Neil E. Fleshner, et al. Active Surveillance plus Enzalutamide Monotherapy vs Active Surveillance Alone in Patients with Low-risk or Intermediate-risk Localized Prostate Cancer: The ENACT Randomized Clinical Trial. JAMA Oncol 2022;8:1128-36
    Rivas, Juan Gomez
    Gandaglia, Giorgio
    Montorsi, Francesco
    [J]. EUROPEAN UROLOGY OPEN SCIENCE, 2022, 46 : 135 - 136
  • [5] Enzalutamide versus active Surveillance in Patients with Low-risk Prostate Cancer
    Dunst, Juergen
    Krug, David
    [J]. STRAHLENTHERAPIE UND ONKOLOGIE, 2023, 199 (02) : 201 - 203
  • [6] A randomized study of enzalutamide in patients with localized prostate cancer undergoing active surveillance (ENACT).
    Shore, Neal D.
    Vourganti, Srinivas
    Silberstein, Jonathan L.
    Brown, Bruce A.
    Wilson, Samuel
    Hollowell, Courtney M. P.
    Cooperberg, Matthew
    Shang, Gwendoline
    Fleshner, Neil Eric
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [7] ENZALUTAMIDE IN PATIENTS WITH LOCALIZED PROSTATE CANCER UNDERGOING ACTIVE SURVEILLANCE: ENACT
    Shore, Neal D.
    Renzulli, Joseph
    Fleshner, Neil E.
    Hollowell, Courtney M. P.
    Vourganti, Srinivas
    Silberstein, Jonathan
    Siddiqui, Rizwan
    Hairston, John
    Elsouda, Dina
    Russell, David
    Cooperberg, Matthew R.
    Tomlins, Scott A.
    [J]. JOURNAL OF UROLOGY, 2021, 206 : E1099 - E1099
  • [8] Active Surveillance for Low-Risk Localized Prostate Cancer
    Large, Michael C.
    Eggener, Scott E.
    [J]. ONCOLOGY-NEW YORK, 2009, 23 (11): : 974 - 979
  • [9] Active surveillance in intermediate-risk prostate cancer
    Klotz, Laurence
    [J]. BJU INTERNATIONAL, 2020, 125 (03) : 346 - 354
  • [10] Active surveillance for intermediate-risk prostate cancer
    M A Dall'Era
    L Klotz
    [J]. Prostate Cancer and Prostatic Diseases, 2017, 20 : 1 - 6
12345